News

Adolescent Brain Blamed for Sexual Risk Taking


 

LONDON – Sexually transmitted diseases in children and adolescents should be considered a problem of the brain rather than of the genitals, according to one expert.

Although largely preventable through the routine use of condoms and through curbing the number of sexual partners, around 15 million new sexually transmitted disease (STD) cases occur in the United States each year. Most of these cases occur in teenagers and young adults.

“To be a teenager means that you get involved in risk-taking behavior,” Dr. Donald E. Greydanus, professor of pediatrics and human development at Michigan State University in Kalamazoo, said at the meeting.

Dr. Greydanus noted that teenagers are more likely than adults to be risk takers, seek out novelty situations, experience emotional intensity and lability, and succumb to peer-group influences, all as a result of underlying neurobiologic mechanisms (Encephale 2009;35[suppl. 6]:S182-9).

“Think of [STDs] not as a genital problem but as a brain disease,” Dr. Greydanus said.

He explained that adolescence is a period when the brain is still developing. While risky sexual behavior is perhaps par for the course among adolescents, all health care professionals need to get involved and help youths understand the risks that they are taking with their health.

“It's amazing how young these kids start being sexually active,” Dr. Greydanus observed in an interview, noting that children as young as 6 years old may reach puberty and begin to engage in sexual intercourse.

“All of us, no matter what field we are in, need to recognize that the majority of teenagers that we see will be sexually active, or soon will be, after we have seen them.”

Adolescents should be screened for STDs at every appropriate opportunity, he advised, and treated accordingly if an STD is diagnosed. Data show that if one STD is present, then there is a good chance there may be another (Sex. Trans. Dis. 1999;26:26-32).

Asking two simple questions – “Are you sexually active?” and “Are you using a condom?” – could help health care professionals have a huge impact on the number of STDs occurring in adolescents, suggested Dr. Greydanus, who also serves as director of the pediatrics program at the university.

The World Health Organization guidelines on the management of sexually transmitted infections provide a good model for the early diagnosis and treatment of STDs without the need to wait for laboratory results.

Dr. Greydanus advised that all clinicians, regardless of their specialty, try to address any likely STDs rather than simply refer, as adolescents might not attend a follow-up appointment or visit a sexual health clinic.

“Whether you are a cardiologist, a neurologist, a generalist – it doesn't matter. We are all in this fight together, and because we are not doing a good job globally, [sexually transmitted] diseases are increasing, not decreasing,” he said.

Adolescents represent a unique group within pediatric care, with distinct physiologic and neurologic development in comparison to infants, children, and adults, said Dr. Russell Viner of the Institute for Child Health, University College London. “The good modern pediatrician must be an expert on adolescent physiology and psychology,” he said.

Dr. Greydanus and Dr. Viner reported that they had no relevant financial disclosures.

Ask adolescents two simple questions: 'Are you sexually active?' and 'Are you using a condom?'

Source DR. GREYDANUS

Recommended Reading

HIV Testing Rates Reached Record Level in 2009
MDedge Family Medicine
Daily Antiretroviral Prophylaxis Cut Risk of HIV Infection
MDedge Family Medicine
Hepatitis C Vaccine Boosted Immune Response
MDedge Family Medicine
Otitis Research Supports New AAP Guidelines
MDedge Family Medicine
Use of Antibiotics for Acute Otitis Media Tx Gets a Boost
MDedge Family Medicine
Parental Diagnosis of AOM Appears to Be Unreliable
MDedge Family Medicine
Bedside Tool May Predict C. difficile Outcomes
MDedge Family Medicine
Fecal Transplantation an Option for Recurrent C. difficile
MDedge Family Medicine
Telaprevir, Boceprevir Improved HCV Cure Rates
MDedge Family Medicine
Pneumococcal Vaccine: Beyond 13 Serotypes
MDedge Family Medicine